FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Denies Insys Syndros Petition

FDA denies an Insys Therapeutics petition asking for restrictions on ANDAs for a generic form of its Syndros.

Human Drugs

FDA Issues Pediatric Guidance Addendum

FDA publishes an International Conference on Harmonization addendum to a 2000 guidance on clinical investigation of medicinal products in the pediatri...

Medical Devices

Ultrasonics Reprocessor Validated for 2 Duodenoscopes

FDA says the Custom Ultrasonics System 83 Plus automated endoscope reprocessor has been validated to effectively disinfect and Olympus and a Pentax du...

Human Drugs

Alembic Pharmaceuticals FDA-483 Issued

FDA releases an FDA-483 with three observations from an inspection at Indias Alembic Pharmaceuticals.

Human Drugs

FDA Expanded Approval for Pacira Pain Drug

FDA approves a Pacira Pharmaceuticals NDA for Exparel (bupivacaine liposome injectable suspension) for expanded use as an interscalene brachial plexus...

Federal Register

Draft Guide on Pediatric Studies for Dermatitis Drugs

Federal Register notice: FDA makes available a draft guidance on Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs....

Federal Register

FDA Draft Guide on Pregnant Women in Clinical Trials

Federal Register notice: FDA makes available a draft guidance on Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trial...

Federal Register

Comments Sought on Cannabis Substances

Federal Register notice: FDA requests comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling cha...

Federal Register

Info Collection Extension on Device Manufacturer Mark

Federal Register notice: FDA has submitted for OMB approval an information collection extension related to its regulation on Prominent and Conspicuous...

Federal Register

Info Collection Extension on Flu Product Event Reporting

Federal Register notice: FDA submits for OMB approval an information collection extension for its Guidance for Industry on Postmarketing Adverse Event...